Free Trial

Ventas (NYSE:VTR) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Ventas logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Q1 results: Ventas reported EPS of $0.11, missing estimates by $0.01, but posted revenue of $1.65B (up 22% YoY) with FFO beating consensus, and management raised FY2026 guidance to $3.82–$3.89 EPS.
  • Growth push and analyst support: The company announced approximately $1.7B of acquisitions (44 communities) to expand its SHOP footprint, while several firms raised price targets, leaving a MarketBeat consensus of "Moderate Buy" with an average target of $90.47.
  • Dividend and balance-sheet/valuation risks: Ventas increased its quarterly dividend to $0.52 (annualized $2.08, 2.4% yield) but carries a very high payout ratio (≈385%), trades at a high P/E (~158.9) and has meaningful leverage (debt/equity ~1.03).
  • Five stocks to consider instead of Ventas.

Ventas (NYSE:VTR - Get Free Report) issued its earnings results on Monday. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.01), Zacks reports. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The firm had revenue of $1.65 billion during the quarter, compared to analysts' expectations of $1.58 billion. During the same quarter last year, the firm earned $0.84 EPS. The business's revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas updated its FY 2026 guidance to 3.820-3.890 EPS.

Ventas Price Performance

NYSE:VTR traded up $1.11 during trading hours on Tuesday, reaching $85.81. The company had a trading volume of 592,867 shares, compared to its average volume of 3,139,151. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The stock has a 50-day moving average of $84.69 and a two-hundred day moving average of $79.78. Ventas has a one year low of $61.76 and a one year high of $88.36. The firm has a market capitalization of $40.80 billion, a PE ratio of 158.89, a PEG ratio of 2.06 and a beta of 0.75.

Ventas Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Tuesday, March 31st. This is a positive change from Ventas's previous quarterly dividend of $0.48. Ventas's payout ratio is 385.19%.

Insider Activity

In related news, EVP Carey S. Roberts sold 35,532 shares of the firm's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president directly owned 72,755 shares of the company's stock, valued at $6,184,175. This trade represents a 32.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer owned 1,114,034 shares of the company's stock, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their position. The SEC filing for this sale provides additional information. 0.53% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ventas

Institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC increased its stake in shares of Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust's stock valued at $545,000 after buying an additional 7,097 shares during the period. Empowered Funds LLC lifted its stake in shares of Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust's stock valued at $576,000 after acquiring an additional 536 shares during the period. Woodline Partners LP lifted its stake in shares of Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust's stock valued at $2,532,000 after acquiring an additional 11,739 shares during the period. Focus Partners Wealth boosted its holdings in Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust's stock valued at $1,486,000 after acquiring an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Ventas in the second quarter valued at about $805,000. 94.18% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. JPMorgan Chase & Co. upped their price target on Ventas from $88.00 to $93.00 and gave the stock an "overweight" rating in a research note on Friday, March 20th. Wells Fargo & Company boosted their target price on Ventas from $88.00 to $93.00 and gave the stock an "overweight" rating in a report on Thursday, March 26th. Citigroup increased their price target on Ventas from $88.00 to $96.00 and gave the company a "buy" rating in a report on Wednesday, February 11th. Mizuho lifted their price target on shares of Ventas from $87.00 to $94.00 and gave the company an "outperform" rating in a research report on Wednesday, March 4th. Finally, Royal Bank Of Canada boosted their price objective on shares of Ventas from $83.00 to $91.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 10th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Ventas presently has an average rating of "Moderate Buy" and an average target price of $90.47.

Read Our Latest Report on VTR

Ventas News Roundup

Here are the key news stories impacting Ventas this week:

  • Positive Sentiment: Q1 results beat expectations — Ventas reported FFO of $0.94/sh and revenue of $1.65B, both above consensus; management highlighted outsized organic growth and occupancy gains in its senior housing operating portfolio, supporting the beat. BusinessWire Press Release
  • Positive Sentiment: Management raised full‑year EPS guidance (FY2026 guidance updated to roughly $3.82–$3.89), implying confidence that occupancy trends and SHOP performance will persist. Analysts had been near the mid‑range, so the bump is supportive for the stock. Seeking Alpha
  • Positive Sentiment: Accretive growth via acquisitions — Ventas announced ~$1.7B of first‑quarter acquisitions (44 communities), expanding its SHOP footprint and feeding future cash flow/FFO growth if integration and occupancy ramps succeed. Senior Housing News
  • Neutral Sentiment: Analyst/metrics writeups note improvement but suggest digging into same‑store trends and SHOP margin details; Zacks and other outlets provide metric-level context on FFO and revenue vs. estimates. Zacks: Key Metrics
  • Neutral Sentiment: Company materials (press release and slide deck) are available for investors who want to review segment-level occupancy, NOI and disposition/acquisition assumptions behind the beat and guidance. Slide Deck
  • Negative Sentiment: Valuation and balance‑sheet considerations: VTR trades at a high P/E on reported metrics and carries meaningful leverage (debt/equity ~1.03; current/quick ratios ~0.67), so further acquisition-funded growth or unexpected operating softness could pressure the multiple. (Background company metrics)

Ventas Company Profile

(Get Free Report)

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Further Reading

Earnings History for Ventas (NYSE:VTR)

Should You Invest $1,000 in Ventas Right Now?

Before you consider Ventas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.

While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines